Figure 2. OS for relapsed and primary... | American Society of Hematology

Figure 2.

$OS for relapsed and primary refractory (R/R) patients with MTCL and MNKCL stratified by histological subtype comparing relapsed vs primary refractory disease. (A-E) Kaplan-Meier curves show OS estimates since the start of second-line treatment for patients with PTCL-NOS (A), AITL (B), ENKTCL (C), ALK+ ALCL (D), and ALK– ALCL (E). Results depicted apply to the global data set of 763 patients for whom information on the start of second-line treatment was available. P values calculated by log-rank test. Prim. Refrac., primary refractory.$

OS for relapsed and primary refractory (R/R) patients with MTCL and MNKCL stratified by histological subtype comparing relapsed vs primary refractory disease. (A-E) Kaplan-Meier curves show OS estimates since the start of second-line treatment for patients with PTCL-NOS (A), AITL (B), ENKTCL (C), ALK⁺ ALCL (D), and ALK^– ALCL (E). Results depicted apply to the global data set of 763 patients for whom information on the start of second-line treatment was available. P values calculated by log-rank test. Prim. Refrac., primary refractory.

This Feature Is Available To Subscribers Only